Time to complete healing of pressure ulcers ‐ not reported · residents of long‐term care (≥ 65 years) with pressure ulcers; inpatients with pressure ulcers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pressure ulcer area (absolute) · residents of long‐term care (≥ 65 years) with pressure ulcers; inpatients with pressure ulcers
1 finding from 1 review
Acceptability of nutritional supplements ‐ not reported · residents of long‐term care (≥ 65 years) with pressure ulcers; inpatients with pressure ulcers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Gastrointestinal adverse events · residents of long‐term care (≥ 65 years) with pressure ulcers; inpatients with pressure ulcers
It is very uncertain whether summary of findings table ‐ Protein, arginine, zinc and antioxidants changes side effects: at least one adverse gastrointestinal event compared with standard diet or placebo (very low certainty).
1 finding from 1 review
Costs ‐ not reported · residents of long‐term care (≥ 65 years) with pressure ulcers; inpatients with pressure ulcers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Health‐related quality of life ‐ not reported · residents of long‐term care (≥ 65 years) with pressure ulcers; inpatients with pressure ulcers
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Vitamin E plus other antioxidants(1 trial; 36 participants) · people with non‐alcohol‐related fatty liver disease (NAFLD)
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Other antioxidants plus other supplements(1 trial; 46 participants) · people with non‐alcohol‐related fatty liver disease (NAFLD)
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Other antioxidants(1 RCT; 99 participants) · people with non‐alcohol‐related fatty liver disease (NAFLD)
It is very uncertain whether the intervention changes other antioxidants(1 RCT; 99 participants) (very low certainty).
1 finding from 1 review
OR 1.67 [0.24, 14.73]
Studies not reported
Very low
Intervention not reported
Phospholipids plus vitamin E plus other antioxidants(1 trial; 138 participants) · people with non‐alcohol‐related fatty liver disease (NAFLD)
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Other antioxidants(3 trials; 191 participants) · people with non‐alcohol‐related fatty liver disease (NAFLD)
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Antioxidants versus placebo: risk of AMS · participants at risk of high altitude illness
The intervention showed no clear difference in antioxidants versus placebo: risk of AMS (low certainty).
1 finding from 1 review
FVC (% predicted) Change from baseline · people with Duchenne muscular dystrophy and progressive respiratory decline
1 finding from 1 review
Frequency of hospitalisation for respiratory infection · people with Duchenne muscular dystrophy and progressive respiratory decline
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Quality of life Assessed by: Pediatric Quality of Life Inventory, change from baseline (0 to 100; 0 = worst outcome, 100 = best outcome) · people with Duchenne muscular dystrophy and progressive respiratory decline
1 finding from 1 review
Serious adverse events · people with Duchenne muscular dystrophy and progressive respiratory decline
Idebenone showed no clear difference in serious adverse events compared with placebo (low certainty).
1 finding from 1 review
Non‐serious adverse events · people with Duchenne muscular dystrophy and progressive respiratory decline
Idebenone showed no clear difference in non‐serious adverse events compared with placebo (low certainty).
1 finding from 1 review
Intervention not reported
Adverse events ‐ Miscarriage№ of participants: 304(3 RCTs) · women with subfertility
The intervention showed no clear difference in adverse events ‐ Miscarriage№ of participants: 304(3 RCTs) (low certainty).
1 finding from 1 review
Intervention not reported
Adverse events ‐ Multiple pregnancy · women with subfertility
The review found no eligible studies for this question.
1 finding from 1 review
Intervention not reported
Adverse events ‐ Gastrointestinal disturbances · women with subfertility
The review found no eligible studies for this question.
1 finding from 1 review